Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies.

被引：0
|
作者：
Louis, K. [1 ]
Viglietti, D. [1 ]
Pievani, D. [1 ]
Aubert, O. [1 ]
Glotz, D. [1 ]
Legendre, C. [1 ]
Zeevi, A. [2 ]
Loupy, A. [1 ]
Lefaucheur, C. [1 ]
机构：
[1] Paris Translat Res Ctr Organ Transplantat, Paris, France
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
310
引用
收藏
页码：449 / 450
页数：2
相关论文
共 50 条
  • [1] CONVERSION FROM CALCINEURIN INHIBITORS TO BELATACEPT IN KIDNEY RECIPIENTS DECREASES THE PATHOGENICITY OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Viglietti, Denis
    Louis, Kevin
    Pievani, Daniele
    Van Huyen, Jean-Paul Duong
    Aubert, Olivier
    Glotz, Denis
    Legendre, Christophe
    Loupy, Alexandre
    Zeevi, Adriana
    Lefaucheur, Carmen
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 81 - 81
  • [2] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [3] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANTATION
    Dziodzio, T.
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P.
    Bielb, M.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oellinger, R.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 11 - 11
  • [4] Pathogenicity of Pre-Transplant Donor-Specific Anti-HLA Antibodies in Heart Transplant Recipients
    Kubanek, M.
    Gazdic, T.
    Svobodova, E.
    Slavcey, A.
    Netuka, I.
    Pirk, J.
    Malek, I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S295 - S296
  • [5] CHARACTERISTICS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS.
    Ghandorah, Salim
    Yilmaz, Serdar
    Abadi, Abdulnaser
    Rahmanian, Taleb
    Wang, Jinguo
    Khan, Faisal M.
    Berka, Noureddine
    [J]. HUMAN IMMUNOLOGY, 2015, 76 : 163 - 163
  • [6] The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
    Alexandre Loupy
    Gary S. Hill
    Stanley C. Jordan
    [J]. Nature Reviews Nephrology, 2012, 8 : 348 - 357
  • [7] Donor-specific anti-HLA antibodies and horizontal ellipsis recipient-specific anti-HLA antibodies? The conundrum on pregnancy in transplantation
    Ciurea, Stefan O.
    Cao, Kai
    Zou, Jun
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (05) : E128 - E130
  • [8] The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
    Loupy, Alexandre
    Hill, Gary S.
    Jordan, Stanley C.
    [J]. NATURE REVIEWS NEPHROLOGY, 2012, 8 (06) : 348 - 357
  • [9] Donor-Specific Anti-HLA Antibodies and the Troubled Kidney: Results from the DeKAF Study
    Cecka, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 44 - 44
  • [10] WHICH PREFORMED DONOR-SPECIFIC ANTI-HLA ANTIBODIES ARE CLINICALLY RELEVANT?
    Salvade, Igor
    Aubert, Vincent
    Venetz, J. P.
    Golshayan, Dela
    Sugamele, Rocco
    Gregoretti, Stephanie
    Pantaleo, Giuseppe
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 70 - 71
12345